Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)

European Journal of Cancer

Volumn 49, Issue 13, 2013, Pages 2910-2918

  Binda, D ^a   Vanhoutte, E K ^b   Cavaletti, G ^a   Cornblath, D R ^c   Postma, T J ^d   Frigeni, B ^a   Alberti, P ^a   Bruna, J ^e   Velasco, R ^e   Argyriou, A A ^f   Kalofonos, H P ^f   Psimaras, D ^g   Ricard, D ^h   Pace, A ⁱ   Galie E ⁱ   Briani, C ^j   Dalla Torre, C ^j   Lalisang, R I ^k   Boogerd, W ^l   Brandsma, D ^l   Koeppen, S ^m   Hense, J ^m   Storey, D ⁿ   Kerrigan, S ⁿ   Schenone, A ^o   Fabbri, S ^o   Rossi, E ^a   Valsecchi, M G ^a   Faber, C G ^b   Merkies, I S J ^b,p   more..

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Unit of Neuro Oncology   (Spain)

^f UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h University of Paris Descartes   (France)

ⁱ REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^j UNIVERSITY OF PADOVA   (Italy)

^k MAASTRICHT UNIVERSITY   (Netherlands)

^l NETHERLANDS CANCER INSTITUTE   (Netherlands)

^m UNIVERSITY HOSPITAL ESSEN   (Germany)

ⁿ WESTERN GENERAL HOSPITAL   (United Kingdom)

^o UNIVERSITY OF GENOA   (Italy)

^p Department of Orthopaedic Surgery   (Netherlands)

more..

Author keywords

Chemotherapy; Disability evaluation; Patient questionnaire; Peripheral neuropathy

Indexed keywords

ADULT; AGED; ARTICLE; CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY; DISABILITY SEVERITY; EXTERNAL VALIDITY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PAIN INTENSITY NUMERIC RATING SCALE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RASCH ANALYSIS; RASCH-BUILT OVERALL DISABILITY SCALE; RELIABILITY; VALIDITY;

CHEMOTHERAPY; DISABILITY EVALUATION; PATIENT QUESTIONNAIRE; PERIPHERAL NEUROPATHY;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHI-SQUARE DISTRIBUTION; CONSENSUS; DISABILITY EVALUATION; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84881096851     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.04.004     Document Type: Article

References (29)

1. G. Cavaletti, P. Alberti, B. Frigeni, M. Piatti, and E. Susani Chemotherapy-induced neuropathy Curr Treat Options Neurol 13 2011 180 190
2. G. Cavaletti, and C. Zanna Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity Eur J Cancer 38 2002 1832 1837
3. S. Wolf, D. Barton, L. Kottschade, A. Grothey, and C. Loprinzi Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies Eur J Cancer 44 2008 1507 1515
4. A. Tennant, and P.G. Conaghan The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Care Res 57 2007 1358 1362
5. J.F. Pallant, and A. Tennant An introduction to the Rasch measurement model: an example using the hospital anxiety and depression scale (HADS) Br J Clin Psychol 46 2007 1 18
6. G. Rasch Probabilistic models for some intelligence and attainment tests 1960 University of Chicago Press Chicago
7. D.L. Streiner, and G.R. Norman Health measurement scales. A practical guide to their development and use 1995 Oxford University Press New York
8. K.A. Griffith, I.S.J. Merkies, E.E. Hill, and D.R. Cornblath Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties J Peripher Nerv Syst 15 2010 314 325
9. G. Cavaletti, B. Frigeni, and F. Lanzani Chemotherapy-induced peripheral neurotoxicity assessment: a critical revision of the currently available tools Eur J Cancer 46 2010 479 494
10. R.F. DeVellis Classical test theory Med Care 44 2006 S50 S59
11. G. Stucki, L. Daltroy, J.N. Katz, M. Johannesson, and M.H. Liang Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts J Clin Epidemiol 49 1996 711 717
12. L.A. Guttman The basis for Scalogram analysis S.A. Stouffer, L.A. Guttman, F.A. Suchman, P.F. Lazarsfeld, S.A. Star, J.A. Clausen, Studies in social psychology in World War II: measurement and prediction 1950 Princeton University Press Princeton 60 90
13. CI-PeriNomS Study Group CI-PeriNomS: chemotherapy-induced peripheral neuropathy outcome measures study J Peripher Nerv Syst 14 2009 69 71
14. G. Cavaletti, D.R. Cornblath, and I.S.J. Merkies The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings Ann Oncol 24 2013 454 462
15. C. Bombardier, and P. Tugwell A methodological framework to develop and select indices for clinical trials: statistical and judgmental approaches J Rheumatol 9 1982 753 757
16. WHO The international classification of functioning, disability and health 2001 World Health Organization Geneva
17. M. Penta, L. Tesio, C. Arnould, A. Zancan, and J.-L. Thonnard The ABILHAND questionnaire as a measure of manual ability in chronic stroke patients: Rasch-based validation and relationship to upper limb impairment Stroke 32 2001 1627 1634
18. Rasch unidimensional measurement models (RUMM2030) [program] 2010 Rumm Laboratory Pty Ltd. Perth, Australia
19. S.I. van Nes, E.K. Vanhoutte, and P.A. van Doorn Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies Neurology 76 2011 337 345
20. J.T. Farrar, J.P. Young Jr., L. LaMoreaux, J.L. Werth, and R.M. Poole Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale Pain 94 2001 149 158
21. A. Trotti, A.D. Colevas, and A. Setser CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181
22. W.P. Fisher Reliability statistics Rasch Meas Trans 6 1992 238
23. J.M. Bland, and D.G. Altman Statistics notes: Cronbach's alpha BMJ 314 1997 572
24. J.M. Bland, and D.G. Altman Multiple significance tests: the Bonferroni method BMJ 310 1995 170
25. J.M. Linacre Sample size and item calibration stability Rasch Meas Trans 7 1994
26. B.D. Wright, and M.H. Stone Best test design 1979 Mesa Press Chicago
27. M.H. Liang Evaluating measurement responsiveness J Rheumatol 22 1995 1191 1192
28. I.S.J. Merkies, G. Lauria, and C.G. Faber Outcome measures in peripheral neuropathies: requirements through statements Curr Opin Neurol 25 2012 556 563
29. M.P. Lunn, J.M. Lèger, I.S. Merkies, P. Van den Bergh, and I.N. van Schaik 151st ENMC international workshop: inflammatory neuropathy consortium 13th-15th April 2007, Schiphol, The Netherlands Neuromuscul Disord 18 2008 85 89